Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Conditions

• Acute Myeloid Leukemia
• Acute Lymphoid Leukemia
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndromes

Interventions

• DRUG: ORCA-T

Sponsor

Stanford University

Collaborators

• [object Object]